Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.
Will E, Bailey J, Schuesler T, Modlich U, Balcik B, Burzynski B, Witte D, Layh-Schmitt G, Rudolph C, Schlegelberger B, von Kalle C, Baum C, Sorrentino BP, Wagner LM, Kelly P, Reeves L, Williams DA.
Mol Ther. 2007 Apr;15(4):782-91. Epub 2007 Feb 13.PMID: 17299409 [PubMed - indexed for MEDLINE]Related articles